bbi-biotech China

innovation for biotech

12/2017 – On Demand Bioreactor systems for the bioproduction of tomorrow


The transfer of technology along the entire value chain has a major influence on the success for innovations in biotechnology. Whether the “tongue as a sensor”, the development of regenerative therapies or new ways in drug development – at this year’s BioBalance, successful projects and new platforms for technology transfer from the Berlin-Brandenburg region are presented.

A special highlight will be the lecture Bioreactor systems “on demand” for the bioproduction of tomorrow by bbi-biotech CEO Bernd-Ulrich Wilhelm, which deals with the different approaches for the (fast) scalability of biotech production processes.


B.-U. Wilhelm bbi-biotech Sampling Systems and PAT in biotechnology bbi-biotech CEO B.-U. Wilhelm

Of course, afterwards it will be possible to discuss different projects and trends in modern biotechnology.

Register here: http://www.healthcapital.de/termine/anmeldung/details/biobilanz-2017/register/25/